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HISTORY OF SCIENCE
CONTRIBUTIONS OF MORIZ KAPOSI TO KNOWLEDGE OF CANCER AND PRECANCEROUS CONDiTIONS: SARCOMA AND XERODERMA PIGMENTOSUM

Anne

J. Krush

The Moore Clinic
The Johns Hopkins Hospital
600 North Wolfe Street
Baltimore, Maryland 21205

Moriz (Moritz, Moric, Moricz) Kaposi, whose original surname was Kohn,
was born in Kaposvar, Hungary on October 23, 1837. Though his parents
were poor, he completed his early education at Pressburg, Bratislava, and in
1861 received an M.D. degree at the University of Vienna. From 1866 to
1869 he was an assistant to Dr. Ferdinand Hebra, founder and chairman of
the Department of Dermatology at the University of Vienna. He proceeded
from "Privatdozent" to associate professor, and later assumed Hebra's chair
until his own death on March 6, 1902. Kaposi was intimately involved in
almost every clinical dermatologic advance of his time. He published widely;
students and patients came from many countries to his clinic in Vienna. His
trainees later occupied chairs of Dermatology at many other European universities. The first descriptions of several dermatologic conditions are attributed
to Kaposi, two of which are pigmented sarcoma ofthe skin (Kaposi's sarcoma)
in 1872 and xeroderma pigmentosum (XDP) in 1882. His descriptive and
clinical studies of patients with XDP antedated the discovery of the recessive
inheritance pattern and the fact that ultraviolet light sets up the mechanism
for malignant melanoma of the skin. He did, indeed, recognize the seriousness
of the condition and its precancerous nature.
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A short time later Kaposi married Dr. Hebra' s daughter.
Still later, he became associate professor of Dermatology; and
after the death of Dr. Hebra in 1881, he became chairman of
Dermatology at the University of Vienna, a post he retained
until his own death on March 6, 1902.
Not only did Kaposi show excellence in his descriptions
and knowledge of many dermatologic conditions, but he was
knowledgeable in the descriptions of their histology and pathology (Braun, 1982). He published many dermatologic papers, and his lectures attracted students, patients, and physicians
from many other countries to his clinic. Kaposi was an excellent
speaker and was invited to speak at many international dermatologic meetings. Many of his students later became chairmen of Dermatology departments in a number of European
countries.
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Two of a number of dermatologic conditions first described
by Kaposi are: idiopathic multiple pigmented sarcoma (Kaposi's sarcoma) in 1872, and xeroderma pigmentosum in 1882.

INTRODUCTION

Moriz (Moritz, Moric, Moricz) Kaposi, whose original surname was Kohn, was born in Kaposvar, Hungary on October
23, 1837, the son of poor parents. His early education was
obtained in Pressburg, Bratislava, and in 1861 he received the
M.D. degree at the University of Vienna. It was there that
Kaposi's interest in dermatology began as he worked as an
assistant to Dr. Ferdinand Hebra who had founded and chaired
the Department of Dermatology at that University. Kaposi soon
became Prlvatdozent at the Allgemeines Krankenhaus after
completing a dissertation on syphilis of the mucous membranes
(Editorial, JAMA, 1964).

KAPOSI'S SARCOMA

In 1872, after having seen andfJlttempted to treat several
patients with an unusual type of sarcoma, Kaposi's description
entitled "Idiopathic Multiple Pigmented Sarcoma of the Skin"
(Kaposi, 1872) was published in the Archives of Dermatology
and Syphilology. It was also published in his book, (Kaposi,
1880).
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In about 1892, after further study, Kaposi suggested another name for this disease, idiopathic multiple hemorrhagic
sarcoma, which he felt best described it. He described 16 cases
of this pigmented sarcoma in men and one boy.
The lesions began on the soles and volar surfaces of the
feet. Then the same surfaces of the hands became affected. He
described the lesions as "reddish brown, later bluish red, round,
moderately firm nodules from the size of a pea to that of a
bean, which are in part separate and irregularly situated, in
part arranged in groups and diffuse infiltrations varying from
the size of a Kreuzer (a quarter) to that of the palm of the hand.
The lesions then appear on the ankles and forearms, and in
two to three years progress to the face and trunk of the body.

Treatment in 1986 for Kaposi's sarcoma
One wonders what Dr. Kaposi would think one hUndred
years after his first description of what is now called "classical
Kaposi's sarcoma" (CKS) as distinguished from "epidemic
Kaposi's sarcoma" (EKS), a frequent complication in patients
with the Auto Immune Deficiency Syndrome (AIDS). Even
before the appearance of AIDS, it was found that patients with
kidney transplants who were chemically immunologically suppressed had not only impairment of the immune reactivity of
the body's lymphocytes, but also many times developed Kaposi's sarcoma (Friedman-Kien and Laubenstein, 1984). This
condition then regressed when the suppressive drugs were discontinued.

"Later, the lesions ulcerate and become gangrenous and
necrotic. " The prognosis was poor because no treatment was
available. If the lesions were surgically removed, others always
appeared. The most difficult symptom was the feeling of tightness and pain in hands and feet for which such palliative prescriptions as emollient ointments, cold compresses, and
paregoric were given (Braun, 1982). In addition to the pain!
the patients suffered from a high fever, bloody diarrhea, hemoptysis, and general debilitation before death occurred. The
patient died within two to three years.

From learning that the body's immune mechanisms are
suppressed in patients with AIDS and that EKS was one of the
opportunistic conditions complicating the disease, new therapies for Kaposi's sarcoma became urgent. They now consist
of radiation therapy for early lesions, chemotherapy, and biologic response modifiers, such as interferon.

At autopsy, large numbers of lesions were also found in
the esophagus, trachea, stomach, heart, liver, and intestinal
tract with especially necrotic lesions in the descending colon
(Editorial, JAMA, 1964). (Some of the lesions were described
as the size of a silver groschen or a thaler.)

Kaposi was the first dermatologist to report xerodelma pigmentosum (XDP) or xeroderma, parchment skin (Shelley and
Crissey, 1953). In one of two young patients (age 18), ll.e noted
abnormality of pigmentation while in the second (age 10) there
was none.

Kaposi removed a number of the sarcomatous lesions to
study them microscopically. He described them as follows: "A
round-cell sarcoma is seen, except that in a few places the
characteristic spindle-cell sarcoma is seen. A peculiarity of this
type is the presence of capillary hemorrhages, which explain
the later bluish-black pigmentation of the originally bluishred nodules, as well as the excessive hardness of the diffuse
infiltrations around the groups of nodules caused by deposits
of fibrin (Editorial, JAMA, 1964).

The first young lady, from one of the northern German
states, had developed XDP in early childhood. Dr. Kaposi first
examined her in 1863 with the following description: "The
skin of the face, ears, throat, neck, shoulders, arms and of the
breast to the level of the third rib . . . had a checkered appearance; it appeared to be abundantly dotted over with pigmented spots, the size of a pin-head or bean, and yellowishbrown in color; it was also tightly stretched, as if contracted,
was pinched up into a fold with difficulty, and felt very thin.
Its surface was smooth in some places, while in others, fine
epidermic lamellae peeled off; or there were quite flat, linear
furrows marked out on the epidermis, so that the surface appeared as dry as parchment, and wrinkled, while the skin,
itself, was tightly stretched. In places, it was of a white color
and was without pigment, while there also existed ... yellowish or dark-brown pigmented spots resembling freckles. . .
Beyond a sensation of tightness, the patient had no pain nor

In recent years the following interesting findings concerning Kaposi's sarcoma are: 1) The ratio of male to female occurrence of the disease is 10: 1; 2) there are racial, geographic
and ethnic factors, with increased occurrences among Northern
Italians, Ashkenazi Jews, and the Bantus of South Africa; and
3) there appear to be a number of familial occurrences so that
an autosomal dominant gene is postulated (Lynch, 1972).

XERODERMA PIGMENTOSUM or XERODERMA,
PARCHMENT SKIN
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itching. The skin of the whole trunk and of the extremities was
quite normal, smooth, pliant, fine. The general state of health
was normal" (Shelley and Crissey, 1953). The skin on this
patient's face had contracted so that her eyelids were drawn
downward and she could not close her eyes, causing ulceration
of the cornea. Her nose was compressed and her ears were
indented in places, all due to the thinning and contraction of
the skin. The patient died at age 27 from "cancer of the peritoneum" that presumably was not related to XPD, though
changes in the patient's immune system may have been a factor.
Since Kaposi's time it has been learned, first, that exposure
to sunlight (ultraviolet light) causes skin alteration in XDP,
melanin deposits (freckles) and, in many cases, malignant melanoma of the skin. Also, it has been learned that XDP is an
autosomal recessive disease. More recently, it has been learned
that whereas in persons with normal skin, ultraviolet light causes
a chain break in the DNA that can be "repaired" (Lynch,
1972), in persons with XPD such a "repair" mechanism is
lacking due to an enzyme deficiency (endonuclease). When
exposed to sunlight or ultraviolet light, the skin shows pathologic changes that include disturbances of pigmentation and
maturation of epidermal cells (Lynch, 1972). Even more recently it has been found that the XPD gene is located on
chromosome 1 (McKusick, 1986).
Effective treatment for XPD now consists of using chemical
sun screens. At an XPD Clinic at the National Institute of
Health, it has been found that accutane, a drug used for treating
acne, also slows tumor growth in XPD.
Thus, Moriz Kaposi provided the initial observations of
two diseases, one malignant and one premalignant, that later
were found to be hereditary.
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